SYRE Competitors & Alternatives
Compare Spyre Therapeutics Inc. with similar stocks in the same industry
Biotechnology
SYRE
Main Stock$92.33
Tradestie Score
38
Market Cap
$994.20M
Analyst Upside
+32.5%
Top Competitors
218 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
IONS
Ionis Pharmaceuticals, Inc. Common Stock
|
$43.91
|
$10.49B | - | 58 | Compare |
|
BBIO
BridgeBio Pharma, Inc. Common Stock
|
$68.12
|
$10.22B | - | 58 | Compare |
|
MDGL
Madrigal Pharmaceuticals, Inc. Common Stock
|
$453.34
|
$10.01B | - | 62 | Compare |
|
TECH
Bio-Techne Corp.
|
$72.62
|
$9.33B | 62.6 | 61 | Compare |
|
CORT
Corcept Therapeutics Inc.
|
$107.50
|
$8.88B | 258.4 | 49 | Compare |
|
HALO
Halozyme Therapeutics, Inc.
|
$124.54
|
$8.77B | 36.5 | 36 | Compare |
|
RVMD
Revolution Medicines, Inc. Common Stock
|
$187.69
|
$8.57B | - | 57 | Compare |
|
CAI
Caris Life Sciences, Inc. Common Stock
|
$31.71
|
$8.53B | 19.1 | 42 | Compare |
|
JAZZ
Jazz Pharmaceuticals, Inc.
|
$214.65
|
$8.30B | 14.5 | 62 | Compare |
|
MRUS
Merus N.V. Common Shares
|
$90.00
|
$7.14B | - | 39 | Compare |
More SYRE Analysis
Data updated: Oct 22, 2026 | Industry: Biotechnology (SIC 2834)
218 stocks in this industry